coating agent: modified maize starch, talc, glycerol, shellac, potassium aluminium silicate, titanium dioxide, azorubine (may impair activity and attention in children!), capsule shell: gelatine
Exenatide (including extended-release formulations) Therapeutic Benefits 1
Of note, in normal cells, persistent activation of NRF2 due to functional defects of KEAP1-mediated NRF2 degradation is sometimes deleterious, while transient activation of NRF2 in response to various stimuli can be beneficial for our health
Exendin-3, a novel peptide from Heloderma horridum venom, interacts with vasoactive intestinal peptide receptors and a newly described receptor on dispersed acini from guinea pig pancreas